Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
A8306 MOG (35-55)1 CitationSummary: Minor component of CNS myelin
-
B5402 TCS PrP Inhibitor 13Summary: Antiprion agent,inhibits protease-resistant prion protein (PrP-res) accumulation
-
B7209 B2Summary: Promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease
-
B7676 ONO 2506Summary: exhibits neuroprotective effects
-
B5247 Nogo-66 (1-40)Summary: competitive antagonist at the Nogo-66 receptor (NgR)
-
B5315 PLP (139-151)Summary: Synthetic myelin proteolipid protein (PLP) fragment
-
B5433 Prion Protein 106-126 (human)Summary: Prion peptide fragment that exhibits neurotoxicity